Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX) -- Ignore unavailable to you. Want to Upgrade?

To: JF Quinnelly who wrote (733)	6/20/1998 9:53:00 PM
From: Dave Williams	Read Replies (1) \| Respond to of 1728

BARS once again on 06/19 published a favorable rating, but no announcements or re-iterations. "Our forecasts call for Affymetrix to turn profitable in the year 2000, a year earlier than our initial estimates. Our forecasts, which we believe are conservative call for EPS of $1.99 in 2002. Based on this, we assign a current fair value for the stock of $34 using a 20% discount rate and a 35 P/E multiple." This was what I had received. Maybe someone can confirm it was a BARS report? PE @ 35 is at the mid/high range.